Our Technology

Our Technology

Our company develops molecular biomarker testing technology for the early detection and prevention of various cancers and pre-cancers.  Our testing technology and platform is objective, highly sensitive and specific, easy-to-use, low cost and non-invasive.

Our company screened human genome and identified novel class of DNA-based biomarkers for various cancers. Our company develops specific quantitation PCR-based assay using biomarkers as a panel, namely the “Cancer Clear™” molecular test.

Data from the Cancer Clear™ test yield over 90% sensitivity and 90% specificity in distinguishing cancer versus normal control tissues.